+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Micardis"

Investigation Report on China's Telmisartan Market, 2018-2022 - Product Thumbnail Image

Investigation Report on China's Telmisartan Market, 2018-2022

  • Report
  • December 2018
  • 30 Pages
  • China
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Micardis is a brand of telmisartan, an angiotensin II receptor blocker (ARB) used to treat hypertension and reduce the risk of cardiovascular events. It is also used to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy. It is available in tablet form and is taken orally. It is usually taken once a day, with or without food. Micardis is part of a larger market of cardiovascular drugs, which are used to treat a variety of conditions related to the heart and blood vessels. These drugs include beta blockers, ACE inhibitors, calcium channel blockers, and diuretics. They are used to treat high blood pressure, angina, heart failure, and other conditions. The market for cardiovascular drugs is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Other companies include AstraZeneca, Bristol-Myers Squibb, and Boehringer Ingelheim. Show Less Read more